NCT05508204View on ClinicalTrials.gov

Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions
Healthy Volunteer
Interventions
DRUG

BION-1301

A solution for SC injection administered as a single dose

Trial Locations (1)

90806

Collaborative Neuroscience Research, LLC, Long Beach

Sponsors
All Listed Sponsors
lead

Chinook Therapeutics, Inc.

INDUSTRY